The virus entry inhibitor ARN-75039 provides therapeutic protection against Lassa virus infection in guinea pigs

Journal:
Science Translational Medicine
Published:
DOI:
10.1126/scitranslmed.adx0938
Affiliations:
2
Authors:
15
Go to article
Institutions Authors Share
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)
10.000000
10.000000
 0.67
Arisan Therapeutics, United States of America (USA)
5.000000
 0.33
Interested in Medical Microbiology?